A Granito Selected Research

Cholesterol

1/2018

Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Granito Research Topics

Disease

5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2013
4	Autoimmune Hepatitis 10/2013 - 01/2004
3	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 09/2007 - 02/2005
3	Liver Diseases (Liver Disease) 09/2007 - 06/2001
3	Atrophy 12/2006 - 06/2001
2	Non-alcoholic Fatty Liver Disease 01/2018 - 01/2004
2	Fibrosis (Cirrhosis) 01/2013 - 11/2005
2	Disease Progression 01/2013 - 11/2002
2	Nervous System Diseases (Neurological Disorders) 03/2006 - 11/2002
1	Diabetes Mellitus 01/2018
1	Overweight 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Hepatitis 10/2013
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2013
1	Infections 01/2008
1	Cryoglobulinemia 01/2008
1	Celiac Disease (Celiac Sprue) 12/2006
1	Autoimmune enteropathy 12/2006
1	Rheumatoid Arthritis 12/2006
1	Cerebellar Ataxia (Dysmetria) 03/2006
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2006
1	Autoimmune Diseases (Autoimmune Disease) 03/2006
1	Chronic Hepatitis C 11/2005
1	Sclerosing Cholangitis 04/2005
1	Crohn Disease (Crohn's Disease) 04/2005
1	Ulcerative Colitis 04/2005
1	Neurologic Manifestations (Neurological Manifestations) 02/2005
1	Thyroid Nodule (Nodule, Thyroid) 01/2001
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2001

Drug/Important Bio-Agent (IBA)

9	AntibodiesIBA 09/2007 - 01/2001
3	AutoantibodiesIBA 10/2013 - 12/2006
3	Antinuclear AntibodiesIBA 09/2007 - 05/2005
2	Immunoglobulin G (IgG)IBA 03/2006 - 04/2005
2	GangliosidesIBA 03/2006 - 02/2005
2	Immunoglobulin A (IgA)IBA 04/2005 - 01/2001
1	atezolizumabIBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 10/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	regorafenibIBA 01/2018
1	CholesterolIBA 01/2018
1	gadolinium ethoxybenzyl DTPA FDA Link 02/2013
1	ARQ 197IBA 01/2013
1	Actins (F Actin)IBA 03/2006
1	Immunoglobulin M (IgM)IBA 03/2006
1	AntigensIBA 03/2006
1	EnzymesIBA 03/2006
1	ImmunosorbentsIBA 03/2006
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2005
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 11/2005
1	Alanine Transaminase (SGPT)IBA 11/2005
1	InterferonsIBA 11/2005
1	Ribavirin (Virazole)FDA LinkGeneric 11/2005
1	Interferon-alpha (Interferon Alfa)IBA 11/2005
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 05/2005
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2005
1	EpitopesIBA 01/2004
1	Recombinant ProteinsIBA 01/2004
1	Transaminases (Aminotransferases)IBA 06/2001
1	anti-transglutaminase autoantibodyIBA 01/2001
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2001

Therapy/Procedure

3	Gluten-Free Diet 01/2018 - 11/2002
2	Therapeutics 11/2005 - 05/2005